Design of biodegradable cellulose filtration material with high efficiency and breathability.


Journal

Carbohydrate polymers
ISSN: 1879-1344
Titre abrégé: Carbohydr Polym
Pays: England
ID NLM: 8307156

Informations de publication

Date de publication:
15 Jul 2024
Historique:
received: 20 11 2023
revised: 27 03 2024
accepted: 04 04 2024
medline: 27 4 2024
pubmed: 27 4 2024
entrez: 26 4 2024
Statut: ppublish

Résumé

Using respiratory protective equipment is one of the relevant preventive measures for infectious diseases, including COVID-19, and for various occupational respiratory hazards. Because experienced discomfort may result in a decrease in the utilization of respirators, it is important to enhance the material properties to resolve suboptimal usage. We combined several technologies to produce a filtration material that met requirements set by a cross-disciplinary interview study on the usability of protective equipment. Improved breathability, environmental sustainability, and comfort of the material were achieved by electrospinning poly(ethylene oxide) (PEO) nanofibers on a thin foam-formed fabric from regenerated cellulose fibers. The high filtration efficiency of sub-micron-sized diethylhexyl sebacate (DEHS) aerosol particles resulted from the small mean segment length of 0.35 μm of the nanofiber network. For a particle diameter of 0.6 μm, the filtration efficiency of a single PEO layer varied in the range of 80-97 % depending on the coat weight. The corresponding pressure drop had the level of 20-90 Pa for the airflow velocity of 5.3 cm/s. Using a multilayer structure, a very high filtration efficiency of 99.5 % was obtained with only a slightly higher pressure drop. This opens a route toward designing sustainable personal protective media with improved user experience.

Identifiants

pubmed: 38670771
pii: S0144-8617(24)00359-X
doi: 10.1016/j.carbpol.2024.122133
pii:
doi:

Substances chimiques

Cellulose 9004-34-6
Polyethylene Glycols 3WJQ0SDW1A
Aerosols 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122133

Informations de copyright

Copyright © 2023. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jukka A Ketoja (JA)

VTT Technical Research Centre of Finland Ltd, P.O. Box 1000, FI-02044 Espoo, Finland. Electronic address: jukka.ketoja@vtt.fi.

Kaisa Saurio (K)

Faculty of Social Sciences, Tampere University, Finland.

Hille Rautkoski (H)

VTT Technical Research Centre of Finland Ltd, P.O. Box 1000, FI-02044 Espoo, Finland.

Eija Kenttä (E)

VTT Technical Research Centre of Finland Ltd, P.O. Box 1000, FI-02044 Espoo, Finland.

Atsushi Tanaka (A)

VTT Technical Research Centre of Finland Ltd, P.O. Box 1000, FI-02044 Espoo, Finland.

Antti I Koponen (AI)

VTT Technical Research Centre of Finland Ltd, P.O. Box 1000, FI-02044 Espoo, Finland.

Jussi Virkajärvi (J)

VTT Technical Research Centre of Finland Ltd, P.O. Box 1000, FI-02044 Espoo, Finland.

Kimmo Heinonen (K)

VTT Technical Research Centre of Finland Ltd, P.O. Box 1000, FI-02044 Espoo, Finland.

Katri Kostamo (K)

Faculty of Social Sciences, Tampere University, Finland.

Anastasia Järvenpää (A)

VTT Technical Research Centre of Finland Ltd, P.O. Box 1000, FI-02044 Espoo, Finland.

Niina Hyry (N)

VTT Technical Research Centre of Finland Ltd, P.O. Box 1000, FI-02044 Espoo, Finland.

Pirjo Heikkilä (P)

VTT Technical Research Centre of Finland Ltd, P.O. Box 1000, FI-02044 Espoo, Finland.

Nelli Hankonen (N)

Faculty of Social Sciences, Tampere University, Finland.

Ali Harlin (A)

VTT Technical Research Centre of Finland Ltd, P.O. Box 1000, FI-02044 Espoo, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH